Effects of methylprednisolone infusions on vital signs in children with headaches

Elaine Heidrich1, Gail Greene, Jessica Weberding

  • 1Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Insights

Pediatric patients receiving intravenous methylprednisolone (IVMP) experienced significant vital sign fluctuations. This highlights the need for standardized monitoring guidelines to ensure patient safety during IVMP infusions.

Area of Science:

  • Pediatric pharmacology
  • Cardiovascular monitoring
  • Patient safety

Background:

  • Intravenous methylprednisolone (IVMP) infusions are linked to adverse cardiovascular effects.
  • Inconsistent monitoring practices in pediatric settings raise patient safety concerns.
  • This study addresses vital sign changes and monitoring during IVMP in children.

Purpose of the Study:

  • To describe vital sign changes in pediatric patients receiving IVMP.
  • To evaluate monitoring practices associated with IVMP infusions.
  • To inform the development of standardized monitoring guidelines.

Main Methods:

  • Retrospective chart review of 74 pediatric patients (ages 5-17) receiving IVMP.
  • Data collection included blood pressure, heart rate, IVMP dosage, and timing.
  • Analysis of ordered vs. performed vital sign monitoring frequency.

Main Results:

  • Half of patients had abnormal vital signs at baseline.
  • A majority experienced >10% vital sign changes after the first IVMP dose.
  • Vital sign changes occurred up to 135.5 hours post-dose, more in older children and with higher doses.

Conclusions:

  • Pediatric patients exhibit significant vital sign fluctuations during IVMP therapy.
  • Current monitoring practices are inconsistent and may require standardization.
  • Prospective studies are needed to establish IVMP-specific monitoring guidelines.
Abstract

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Increased Intracranial Pressure l: Introduction01:14

Increased Intracranial Pressure l: Introduction

Intracranial hypertension is a sustained elevation of intracranial pressure (ICP) above 22 mm Hg. In supine adults, normal ICP is ~7–15 mm Hg.The rigid, nonexpandable cranium contains three components—brain tissue, blood, and cerebrospinal fluid (CSF)—that total ~1,700 mL in a typical adult: 1,400 mL brain (~80%), 150 mL blood (~10%), and 150 mL CSF (~10%). According to the Monro–Kellie doctrine, total intracranial volume is effectively fixed. When one component expands, CSF and venous blood...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...